Pacific Biosciences Of California reported $16.86M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Accelerate Diagnostics AXDX:US 1.74M 124K
Agilent A:US $ 734M 26M
Bruker BRKR:US $ 290.2M 14.2M
Danaher DHR:US $ 2821M 216M
Fluidigm FLDM:US $ 14.6M 0.84M
General Electric GE:US $ 13680M 952M
Genmark Diagnostics GNMK:US $ 30.68M 4.58M
Illumina ILMN:US $ 324M 5M
Luminex LMNX:US $ 44.23M 2.72M
Myriad Genetics MYGN:US $ 53.7M 3.4M
Nanostring Technologies NSTG:US $ 15.48M 0.14M
Oxford Immunotec Global OXFD:US $ 4.58M 2.41M
Pacific Biosciences Of California PACB:US $ 16.86M 0.84M
Perkinelmer PKI:US $ 543.28M 20.73M
Quidel QDEL:US $ 70.42M 2.96M
Thermo Fisher Scientific TMO:US $ 4585M 112M
Waters WAT:US $ 280.25M 26.11M